Asia-Pacific Infertility Testing Market, By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Other), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies and Drug Stores), End User (Fertility Centers, Hospitals and Clinics, Research Institutes, Cryobanks), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific)- Industry Trends and Forecast to 2029.
Market Analysis and Insights: Asia-Pacific Infertility Testing Market
Asia-Pacific infertility testing market is expected to witness market growth at a rate of 7.95% in the forecast period of 2022 to 2029. Data Bridge Market Research report on Asia-Pacific infertility testing market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in healthcare sector globally is escalating the growth of Asia-Pacific infertility testing market.
Fertility testing refers to the type of test that is undertaken by both men and women for the purpose of assessing their fertility and various conditions associated with it. Both men and women are known to experience fertility problems at equal rates, but women are considered to be more concerned regarding the test.
The decline in fertility rate across the region acts as one of the major factors driving the growth of infertility testing market. The surge in the sales of fertility test kits and devices owning to the increased the birth rate increased during the lockdown period, and adoption of unhealthy lifestyle accelerate the market growth. The emergence of combined kits for dual testing of pregnancy and ovulation, and increase in online sales of fertility testing devices further influence the market. Additionally, rise in demand for advanced and innovative technologies, surge in healthcare expenditure and implementation of mitigation practices positively affects the infertility testing market. Furthermore, high cost and low accuracy of IVF treatment extend profitable opportunity to the market players in the forecast period of 2022 to 2029.
On the other hand, high cost associated with the fertility testing monitors and lesser precision of ovulation prediction kits are expected to obstruct the market growth. Unproven accuracy of urine-based ovulation monitors in PCOS/PCOD patients is projected to challenge the infertility testing market in the forecast period of 2022-2029.
This infertility testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on infertility testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Infertility Testing Market Scope and Market Size
The infertility testing market is segmented on the basis of type, test kits, prescription mode, distribution channel and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the infertility testing market is segmented into female infertility testing and male infertility testing. The female infertility testing is further sub-segmented into ovulation testing, hysterosalpingography, laparoscopy, transvaginal ultrasound, ovarian reserve testing, hormone testing and others. The male infertility testing is further sub-segmented into DNA fragmentation, oxidative stress analysis, sperm penetration assay, computer aided semen analysis, sperm agglutination assay, microscopic examination and others.
- On the basis of test kits, the infertility testing market is segmented into follicular stimulating hormone (FSH) urine test kits, luteinizing hormone (LH) urine test kits, human chorionic gonadotropin (HCG) hormone blood test kits and other.
- On the basis of prescription mode, the infertility testing market is segmented into prescription based, over the counter (OTC) based.
- On the basis of distribution channel, the infertility testing market is segmented into hospitals pharmacies, online pharmacies and pharmacies and drug stores.
- On the basis of end user, the infertility testing market is segmented into fertility centers, hospitals and clinics, research institutes and cryobanks.
Asia-Pacific Vital Signs Monitoring Market Country Level Analysis
The infertility testing market is analyzed and market size insights and trends are provided by country, type, test kits, prescription mode, distribution channel and end user as referenced above.
The countries covered in the Asia-Pacific infertility testing market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
Japan dominates the Asia-Pacific infertility testing market owning to the technological advancements in the region. China is expected to witness high growth during the forecast period of 2022 to 2029 because of the growing demand for advanced devices.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Asia-Pacific infertility testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific infertility testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific infertility testing market. The data is available for historic period 2010-2020.
Competitive Landscape and Asia-Pacific Infertility Testing Market Share Analysis
The infertility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to infertility testing market.
Some of the major players operating in the infertility testing market report are Halotech DNA, Procter & Gamble, Andrology Solutions, SA Scientific, bioMérieux SA, Abbott, Quidel Corporation, Atlas Medical Uk, Babystart Ltd., SCSA Diagnostics, Gem Medic Technology Co. Ltd., Merck KGaA, bioZhena Corporation, Vitrolife, Progyny Inc., Ferring B.V., and FUJIFILM Irvine Scientific among others.